NCBI: db=pubmed; Term=head and neck
8 followers 0 articles/week
Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers

Cancer Cell Int. 2022 Aug 13;22(1):254. doi: 10.1186/s12935-022-02676-x.ABSTRACTPI3K/AKT pathway is an important pathway in the carcinogenesis since it has central impacts in the regulation of metabolic pathways, cell proliferation and survival, gene expression and protein synthesis. This pathway has been reported to be dysregulated in several types...

Sun Aug 14, 2022 08:43
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer

Radiat Oncol. 2022 Aug 13;17(1):141. doi: 10.1186/s13014-022-02112-4.ABSTRACTBACKGROUND: Systemic inflammation is predictive of the overall survival in cancer patients and is related to the density of immune cells in the tumor microenvironment of cancer, which in turn correlates with 18F -fluorodeoxyglucose (FDG)-positron emission tomography/computed...

Sun Aug 14, 2022 08:43
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma

J Cancer Res Clin Oncol. 2022 Aug 13. doi: 10.1007/s00432-022-04277-7. Online ahead of print.ABSTRACTPURPOSE: Strategies for Indolamine-2,3-dioxygenase 1 (IDO1) inhibition in cancer immunotherapy once produced encouraging results, but failed in clinical trials. Recent evidence indicates that immune cells in the tumour microenvironment, especially macrophages,...

Sun Aug 14, 2022 08:43
Poroma: A Retrospective Series of 80 Patients at a Tertiary Care Hospital

Actas Dermosifiliogr. 2022 Aug 10:S0001-7310(22)00686-X. doi: 10.1016/j.ad.2022.07.019. Online ahead of print.ABSTRACTBACKGROUND: Poroma is a benign, exclusively cutaneous, adnexal tumor with a predilection for palmoplantar skin.OBJECTIVE: To analyze the clinical characteristics of poroma in our population.MATERIAL AND METHODS: Retrospective study of...

Sun Aug 14, 2022 08:43
Use of biologics for treatment of autoimmune inner ear disease

Am J Otolaryngol. 2022 Aug 5;43(5):103576. doi: 10.1016/j.amjoto.2022.103576. Online ahead of print.ABSTRACTOBJECTIVE: Biologic medications are novel therapeutics in the treatment of Autoimmune Inner Ear Disease (AIED), an etiology of Sensorineural Hearing Loss (SNHL). The goal of this study is to review the currently available literature on the efficacy...

Sun Aug 14, 2022 08:43
Tuberculosis of the middle ear: A systematic review

Am J Otolaryngol. 2022 Aug 6;43(5):103571. doi: 10.1016/j.amjoto.2022.103571. Online ahead of print.ABSTRACTOBJECTIVE: Tuberculous otitis media (TOM) is a rare extrapulmonary manifestation of tuberculosis (TB) and remains challenging to diagnose due to non-specific symptoms. This systematic review identifies clinical characteristics, diagnostic evaluation,...

Sun Aug 14, 2022 08:43

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account